Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

Pmv Pharmaceuticals Inc

PMVP

Current price

1.02 USD +0.02 USD (+2.00%)

Last closed 0.96 USD

Company www.pmvpharma.com

ISIN US69353Y1038

Sector Healthcare

Industry Biotechnology

Exchange NASDAQ

Capitalization 52 972 272 USD

Yield for 12 month -41.04 %

10Y

15Y

PMVP

21.11.2021 - 28.11.2021

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey. Address: 400 Alexander Park Drive, Princeton, NJ, United States, 08540

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Activate

View

Very dangerous

View

Very dangerous

Activate

View

Analytics

WallStreet Target Price

5.80 USD

P/E ratio

–

Dividend Yield

–

Revenue
Profit

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

Current Year

–

Last Year

-1 257 000 USD

Current Quarter

–

Last Quarter

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

EBITDA -83 707 000 USD

Operating Margin TTM –

Price to Earnings –

Return On Assets TTM -23.92 %

PEG Ratio –

Return On Equity TTM -29.23 %

Wall Street Target Price 5.80 USD

Revenue TTM –

Book Value 3.39 USD

Revenue Per Share TTM

Dividend Share –

Quarterly Revenue Growth YOY –

Dividend Yield –

Gross Profit TTM –

Earnings per share -1.16 USD

Diluted Eps TTM -1.16 USD

Most Recent Quarter IV 2024

Quarterly Earnings Growth YOY –

Profit Margin –

Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

–

5Y Dividend Growth

–

Consecutive Years

–

5Y Average Payout Ratio

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Ex Dividend Date –

Dividend CAGR 3Y –

Dividend CAGR 5Y –

Dividend CAGR 10Y –

Consecutive Years

Consistent Years

Continuous Dividends

Forward Annual Dividend Yield –

Forward Annual Dividend – USD

Last Split Factor –

Payout Ratio –

Last Split Date –

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Trailing PE –

Forward PE –

Enterprise Value Revenue –

Price Sales TTM –

Enterprise Value EBITDA 1.24

Price Book MRQ 0.30

Financials PMVP

1 year

3 years

5 years

10 years

15 years

Track key metrics for each stock in one place without the hassle

Get Premium

Results	2019	Dynamics

* The data for this period has not yet been published

0.82 USD 2.26 USD

50 Day MA 1.22 USD

Shares Short Prior Month 886 286

200 Day MA 1.46 USD

Short Ratio 7.72

Shares Short 837 513

Short Percent 1.89 %

	All Time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

Pmv Pharmaceuticals Inc